Leveraging artificial intelligence, big data, and new technologies, digital-intelligence development has brought disruptive transformation to clinical trials—Accelerate trial progress, optimize data analysis, and enhance research efficiency.In an industry landscape characterized by rapid and constant change, the importance of clinical supply management is increasing day by day.Enhanced research experience, accelerated time-to-market, and reduced overall costs,can bring significant benefits to research projects.
2023 Digital Intelligence Clinical Supply Forum & The 6th China IRT Forum,Scheduled to be held on May 19 at the Aloft Shanghai Zhangjiang Haike Hotel. This forum, in collaboration with multipleExpert in Clinical Biostatistics, Operations, and Supply Chain at Pharmaceutical Companies, will bring brilliant industry insights sharing and discussions, and invite multipleKeynote SpeakerRoundtable Discussion on the “Guiding Principles for Blinding in Drug Clinical Trials”
On the day,Shanhu Health Will Officially Announce Strategic Partnership with the School of Public Health, Nanjing Medical UniversityBoth parties pool their expertise and resources to break through traditional boundaries, driving faster and more precise digital-intelligent innovation in the clinical trial industry.
Accelerating the Digital and Intelligent Transformation of the Ecosystem, Unleashing Digital Productivity
Adapting to the Times, Empowered by Digital Intelligence
The New Era of Supply Chains
Digital Intelligence Clinical Supply Forum
We cordially invite industry colleagues to attend in person.

Figure: Agenda for the Digital Intelligence Clinical Supply Forum
May 19, 2023 (Friday) 13:00–17:30
Aloft Shanghai Zhangjiang Haike (No. 550, Haike Road, Zhangjiang, Pudong New Area, Shanghai)
About the School of Public Health, Nanjing Medical University
Nanjing Medical University is one of the earliest institutions in China to offer education in public health and preventive medicine. The discipline of public health and preventive medicine received an A+ rating in the national discipline assessment, ranked first in the “ShanghaiRanking’s Best Chinese Subjects” for four consecutive years, and was included in the list of disciplines for the national “Double First-Class” Initiative in 2022. The School has been selected for the national initiative to build high-level schools of public health, extensively engages in scientific and technological services, and has developed distinctive strengths characterized by “strong integration of foundational disciplines and coordinated development of industry, academia, and research.”
Shanhu Health cordially invites clinical research partners to discuss the digital and intelligent future of the industry and usher in a new era for the supply chain.Shanhu Jun has prepared exquisite merchandise gift bags for attendees—register now!